Pages that link to "Q47709495"

The following pages link to Joseph L. McClay (Q47709495):

Displaying 44 items.

• Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs (Q24630309) (← links)
• Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene (Q27860482) (← links)
• Role of genotype in the cycle of violence in maltreated children (Q28216871) (← links)
• Genotype-based ancestral background consistently predicts efficacy and side effects across treatments in CATIE and STAR*D (Q28486019) (← links)
• A comprehensive family-based replication study of schizophrenia genes (Q29417040) (← links)
• In silico whole genome association scan for murine prepulse inhibition (Q30490152) (← links)
• Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure (Q30538147) (← links)
• Refinement of schizophrenia GWAS loci using methylome-wide association data (Q30857458) (← links)
• Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics. (Q33926334) (← links)
• SNP-based analysis of neuroactive ligand-receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: data from the CATIE study (Q34078643) (← links)
• Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction (Q34415424) (← links)
• Genome-wide and gene-based association studies of anxiety disorders in European and African American samples (Q34447563) (← links)
• Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. (Q34661875) (← links)
• Genomewide association study of movement-related adverse antipsychotic effects (Q35010386) (← links)
• Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults (Q35090701) (← links)
• MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders (Q35216295) (← links)
• Combined Whole Methylome and Genomewide Association Study Implicates CNTN4 in Alcohol Use (Q35889359) (← links)
• Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration (Q35987580) (← links)
• Genome-wide association study of antipsychotic-induced QTc interval prolongation (Q36073692) (← links)
• Deep Sequencing of 71 Candidate Genes to Characterize Variation Associated with Alcohol Dependence. (Q36280198) (← links)
• High density methylation QTL analysis in human blood via next-generation sequencing of the methylated genomic DNA fraction (Q36424823) (← links)
• The influence of five monoamine genes on trajectories of depressive symptoms across adolescence and young adulthood (Q36448838) (← links)
• Genes, environments, and developmental research: methods for a multi-site study of early substance abuse (Q36721624) (← links)
• AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families (Q36739834) (← links)
• A systematic method for estimating individual responses to treatment with antipsychotics in CATIE. (Q37120211) (← links)
• A methylome-wide study of aging using massively parallel sequencing of the methyl-CpG-enriched genomic fraction from blood in over 700 subjects (Q37572145) (← links)
• Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment (Q37581282) (← links)
• Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization (Q37581290) (← links)
• MBD-seq as a cost-effective approach for methylome-wide association studies: demonstration in 1500 case--control samples (Q37581443) (← links)
• Deep Sequencing of Three Loci Implicated in Large-Scale Genome-Wide Association Study Smoking Meta-Analyses. (Q41474054) (← links)
• Genetics and diagnostic refinement. (Q42605907) (← links)
• (1)H nuclear magnetic resonance metabolomics analysis identifies novel urinary biomarkers for lung function (Q43090703) (← links)
• Variance component analysis of polymorphic metabolic systems (Q44915281) (← links)
• Catechol-O-methyltransferase and the clinical features of psychosis. (Q44922685) (← links)
• A region of 35 kb containing the trace amine associate receptor 6 (TAAR6) gene is associated with schizophrenia in the Irish study of high-density schizophrenia families. (Q44929435) (← links)
• Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1b (Q45051325) (← links)
• High-Throughput Single-Nucleotide Polymorphism Genotyping by Fluorescent Competitive Allele-Specific Polymerase Chain Reaction (SNiPTag) (Q60641465) (← links)
• Institutional Profile: The Center for Biomarker Research and Personalized Medicine at Virginia Commonwealth University: advancing psychiatric drug treatment (Q61422574) (← links)
• Microbial genetics: Split genes uncovered through science fusion (Q61422700) (← links)
• Building a schizophrenia genetic network: transcription factor 4 regulates genes involved in neuronal development and schizophrenia risk (Q89113653) (← links)
• DNA methylation and histone acetylation changes to cytochrome P450 2E1 regulation in normal aging and impact on rates of drug metabolism in the liver (Q90716412) (← links)
• The ANKS1B gene and its associated phenotypes: focus on CNS drug response (Q93097385) (← links)
• Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microglia (Q93151954) (← links)
• Wikidata:University of Virginia/Listeria/Common topics of publications co-authored by Virginia Commonwealth University people (← links | edit)